Events World Vaccine Congress US Date: 18 - 21 April 2022 Location: Washington, USA Contact: Bjorn te Boekhorst It’s time…tristan4 January 2022
Events World Vaccine Congress Europe Date: 10 - 13 October 2022 Location: Barcelona, Spain Contact: Pieter-Jan Vos We will be…tristan4 January 2022
News Batavia Biosciences partners with CJ CheilJedang to propel its business expansion Batavia Biosciences is proud to announce that CJ CheilJedang (Seoul, South Korea) has selected the…tristan8 November 2021
Blog How to devise a drug development plan that actually works A well-crafted product development plan (PDP) can play a pivotal role in the development and…tristan28 October 2021
News Batavia’s HIP-Vax® selected to propel IAVI’s VSV-vector based Sudan ebolavirus vaccine candidate from bench to clinic Leiden, The Netherlands, October 28, 2021 – Batavia Biosciences is pleased to announce today that…tristan28 October 2021
Blog How to turn an innovative drug candidate into a commercial success – the product development plan explained Without doubt, biotech startups and smaller pharmaceutical companies have become the major drivers of innovation…tristan11 October 2021
Blog Biotech startups – understanding the ecosystem for success Biotechnology is in the midst of a great era of innovation, with an ever-expanding toolbox…tristan28 September 2021
Scientific publication AdV-20-42-42, promising adenoviral vector for gene therapy and vaccine product development Adenoviruses are being explored as vectors for vaccines against various infectious diseases, such as COVID-19,…tristan17 September 2021
Scientific publication Stable, high yield expression of HIV gp145 We are proud to announce that the peer-reviewed journal Biologicals has now published our work…tristan6 September 2021
News Batavia Biosciences is expanding its viral vector process development capacity in Massachusetts Today, Batavia Biosciences announces the expansion of its process development facilities in Woburn, MA, United…tristan31 August 2021